Go Pro
Tom Stephan

Tom Stephan Analyst Performance

Vice President of Healthcare Equity Research at Stifel Nicolaus

Tom Stephan is a stock analyst at Stifel Nicolaus focused in the medical sector, covering 9 publicly traded companies. Over the past year, Tom Stephan has issued 13 stock ratings, including buy and hold recommendations. While full access to Tom Stephan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Tom Stephan's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
15 Last 1 Years
Buy Recommendations
33.33% 4 Buy Ratings
Companies Covered
9 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy33.3%4 ratings
Hold66.7%8 ratings
Sell0.0%0 ratings

Out of 12 total stock ratings issued by Tom Stephan at Stifel Nicolaus, the majority (66.7%) have been Hold recommendations, followed by 33.3% Buy.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
55.6% of companies on NASDAQ
5 companies
NYSE
44.4% of companies on NYSE
4 companies

Tom Stephan, an analyst at Stifel Nicolaus, currently covers 9 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
8 companies
88.9%
Manufacturing
1 company
11.1%

Tom Stephan of Stifel Nicolaus specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
7 companies
77.8%
SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES
1 company
11.1%
MEDICAL SERVICES
1 company
11.1%

About Tom Stephan

Thomas Stephan joined Stifel in 2016. Based out of the New York office, Mr. Stephan is an Associate Vice President in the Healthcare sector, covering Medical Technology & Supplies. Mr. Stephan is a graduate of the University of Notre Dame, where he earned a Bachelor of Business Administration in Finance from the Mendoza College of Business.
Follow on LinkedIn

Tom Stephan's Ratings History at Stifel Nicolaus

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Glaukos Corporation stock logo
GKOS
Glaukos
7/17/2026Boost Price Target$155.41$175.00Buy
Globus Medical, Inc. stock logo
GMED
Globus Medical
7/8/2026Lower Price Target$75.52$80.00Hold
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
7/8/2026Lower Price Target$8.97$13.00Buy
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
6/18/2026Boost Price Target$73.22$80.00Hold
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6/9/2026Set Price Target$13.05$16.00
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
5/26/2026Lower Price Target$69.45$75.00Hold
RxSight, Inc. stock logo
RXST
RxSight
3/9/2026Lower Price Target$7.69$9.00Hold
Spyglass Pharma, Inc. stock logo
SGP
Spyglass Pharma
3/3/2026Initiated Coverage$26.73$42.00Buy
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
2/19/2026Set Price Target$17.64$16.00
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
2/17/2026Boost Price Target$17.36$15.00Hold
RxSight, Inc. stock logo
RXST
RxSight
11/6/2025Set Price Target$8.73$10.00
Alcon stock logo
ALC
Alcon
8/21/2025Lower Price Target$81.04$90.00Buy
RxSight, Inc. stock logo
RXST
RxSight
8/8/2025Lower Price Target$7.13$8.00Hold
RxSight, Inc. stock logo
RXST
RxSight
7/9/2025Lower Price Target$12.79$9.00Hold
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
4/3/2025Lower Price Target$13.48$15.00Hold